Optimising the impact of COVID-19 vaccination on mortality and hospitalisations using an individual additive risk measuring approach based on a risk adjustment scheme

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Danny Wende - , Chair of Quantitative Methods, esp Econometrics, BARMER Institute for Health Systems Research (Author)
  • Dagmar Hertle - , BARMER Institute for Health Systems Research (Author)
  • Claudia Schulte - , BARMER Institute for Health Systems Research (Author)
  • Pedro Ballesteros - , BARMER Institute for Health Systems Research (Author)
  • Uwe Repschläger - , BARMER Institute for Health Systems Research (Author)

Abstract

In this population-based cohort study, billing data from German statutory health insurance (BARMER, 10% of population) are used to develop a prioritisation model for COVID-19 vaccinations based on cumulative underlying conditions. Using a morbidity-based classification system, prevalence and risks for COVID-19-related hospitalisations, ventilations and deaths are estimated. Trisomies, behavioural and developmental disorders (relative risk: 2.09), dementia and organic psychoorganic syndromes (POS) (2.23) and (metastasised) malignant neoplasms (1.99) were identified as the most important conditions for escalations of COVID-19 infection. Moreover, optimal vaccination priority schedules for participants are established on the basis of individual cumulative escalation risk and are compared to the prioritisation scheme chosen by the German Government. We estimate how many people would have already received a vaccination prior to escalation. Vaccination schedules based on individual cumulative risk are shown to be 85% faster than random schedules in preventing deaths, and as much as 57% faster than the German approach, which was based primarily on age and specific diseases. In terms of hospitalisation avoidance, the individual cumulative risk approach was 51% and 28% faster. On this basis, it is concluded that using individual cumulative risk-based vaccination schedules, healthcare systems can be relieved and escalations more optimally avoided.

Details

Original languageEnglish
Pages (from-to)969-978
Number of pages10
JournalEuropean Journal of Health Economics
Volume23
Issue number6
Publication statusPublished - Aug 2022
Peer-reviewedYes

External IDs

PubMed 34799804

Keywords

Sustainable Development Goals

Keywords

  • Additive risk measuring, COVID-19, Immunization strategy, Risk adjustment scheme, Severe outcomes, Vaccination prioritisation